Skip to main navigation Skip to search Skip to main content

Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites

  • Sasha V. Siegel
  • , Hidayat Trimarsanto
  • , Roberto Amato
  • , Kathryn Murie
  • , Aimee R. Taylor
  • , Edwin Sutanto
  • , Mariana Kleinecke
  • , Georgia Whitton
  • , James A. Watson
  • , Mallika Imwong
  • , Ashenafi Assefa
  • , Awab Ghulam Rahim
  • , Hoang Chau Nguyen
  • , Tinh Hien Tran
  • , Justin A. Green
  • , Gavin C.K.W. Koh
  • , Nicholas J. White
  • , Nicholas Day
  • , Dominic P. Kwiatkowski
  • , Julian C. Rayner
  • Ric N. Price, Sarah Auburn
  • Wellcome Trust Sanger Institute
  • Menzies School of Health Research
  • National Research and Innovation Agency (BRIN)
  • Universite Paris Cite
  • Exeins Health Initiative
  • Nuffield Department of Medicine
  • Oxford University Clinical Research Unit
  • Ethiopian Public Health Institute
  • University of North Carolina at Chapel Hill
  • Mahidol University
  • Afghan International Islamic University (AIIU)
  • Formerly GlaxoSmithKline
  • Northwick Park Hospital
  • Cambridge Institute of Medical Research

Research output: Contribution to journal › Article › peer-review

15 Citations (Scopus)

Abstract

Challenges in classifying recurrent Plasmodium vivax infections constrain surveillance of antimalarial efficacy and transmission. Recurrent infections may arise from activation of dormant liver stages (relapse), blood-stage treatment failure (recrudescence) or reinfection. Molecular inference of familial relatedness (identity-by-descent or IBD) can help resolve the probable origin of recurrences. As whole genome sequencing of P. vivax remains challenging, targeted genotyping methods are needed for scalability. We describe a P. vivax marker discovery framework to identify and select panels of microhaplotypes (multi-allelic markers within small, amplifiable segments of the genome) that can accurately capture IBD. We evaluate panels of 50–250 microhaplotypes discovered in a global set of 615 P. vivax genomes. A candidate global 100-microhaplotype panel exhibits high marker diversity in the Asia-Pacific, Latin America and horn of Africa (median HE = 0.70–0.81) and identifies 89% of the polyclonal infections detected with genome-wide datasets. Data simulations reveal lower error in estimating pairwise IBD using microhaplotypes relative to traditional biallelic SNP barcodes. The candidate global panel also exhibits high accuracy in predicting geographic origin and captures local infection outbreak and bottlenecking events. Our framework is open-source enabling customised microhaplotype discovery and selection, with potential for porting to other species or data resources.

Original languageEnglish
Article number6757
JournalNature Communications
Volume15
Issue number1
DOIs
Publication statusPublished - Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites'. Together they form a unique fingerprint.

Cite this